Effects of pamidronate on the development of changes in bone mechanical properties and bone structure caused by the administration of prednisolone in rats

Polish Journal of Pharmacology

Volumn 50, Issue 3, 1998, Pages 253-258

  Tkocz Kwiatkowska, Jolanta ^a   Kaczmarczyk Sedlak, Ilona ^a   Folwarczna, Joanna ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Bone growth; Bone structure; Mechanical properties of bones; Pamidronate; Prednisolone; Prednisolone induced osteopenia

Indexed keywords

PAMIDRONIC ACID; PREDNISOLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE GROWTH; BONE STRENGTH; CONTROLLED STUDY; DRUG INHIBITION; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NONHUMAN; OSTEOGENESIS IMPERFECTA; OSTEOPENIA; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOMECHANICS; BONE AND BONES; BONE DEVELOPMENT; BONE DISEASES, METABOLIC; DIPHOSPHONATES; FRACTURES, BONE; MALE; PREDNISOLONE; RATS;

EID: 0031829894     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Aaron J. E., Johnson D. R., Paxton S., Kanis J. A.: Secondary osteoporosis and the microanatomy of trabecular bone. Clin. Rheumatol., 1989, 8, 84-92.
2. Badurski J., Sawicki A., Boczoń S.: Osteoporosis (Polish). Osteoprint, Białystok, 1994.
3. Fleisch H.: Bisphosphonates in osteoporosis: an introduction. Osteoporosis Int., 1993, Suppl. 3, S3-5.
4. Jee W. S. S., Black H. E., Gotcher J. E.: Effect of dichloromethane diphosphonate on cortisol-induced bone loss in young adult rabbits. Clin. Orthop., 1981, 156, 39-51.
5. Jones G., Sambrook Ph.: Drug-induced disorders of bone metabolism. Drug Safety, 1994, 10, 480-489.
6. Kaczmarczyk-Sedlak I.: Biphosphonates (Polish). Farm. Pol., 1994, 50, 16-26.
7. Kaczmarczyk-Sedlak I.: The effects of pamidronate on mechanical properties, growth and structural changes in rat bones. Acta Poloniae Pharm. - Drug Res., 1995, 52, 509-513.
8. Lin J. H.: Bisphosphonates: a review of their pharmacokinetic properties. Bone, 1996, 18, 75-85.
9. Morgan D. B., Monod A., Russel R. G. G.: Influence of dichlormethylene diphosphonate and calcitonin on bone resorption, lactate production and phosphatase and pyrophosphatase content of mouse calvaria treated with parathyroid hormone in vitro. Calcified Tissue Res., 1973, 13, 287-289.
10. Papapoulos S. E., Landman J. O., Bijvoet O. L. M., Löwik C. W. G. M., Valkmana R., Pauwels E. K. J., Vermeij P.: The use of bisphosphonates in the treatment of osteoporosis. Bone, 1992, 13, S41-S49.
11. Patel S., Lyons A. R., Hosking D. J.: Drugs used in the treatment of metabolic bone disease. Drugs, 1993, 46, 604-606.
12. Plasmans C. M. T., Jap P. H. K., Kuipers W.: Influence of a diphosphonate on the cellular aspect of young bone tissue. Calcified Tissue Int., 1980, 32, 247-226.
13. Russel R. G. G., Mühlbauer R. C., Bisaz S.: The influence of pyrophosphate, condensed phosphates, phosphonates and other phosphate compounds on the dissolution of hydroxyapatite in vitro and on bone resorption induced by parathyroid hormone in tissue culture and in thyroparathyroidectomized rats. Calcified Tissue Res., 1970, 6, 183-196.
14. Schenk R., Merz W. A., Mühlbauer R. C.: Effect of ethane-1-hydroxy-1,1-diphosphonate and dichloromethylene diphosphonate on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats. Calcified Tissue Res., 1973, 11, 196-214.
15. Tripp E.J., MacKay E. H.: Silver staining of bone prior to decalcification for quantitative determination of osteoid in sections. Stain Technol., 1972, 47, 129-131.
16. Wolinsky-Friedland M.: Drug-induced metabolic bone disease. Endocrinol. Metab. Clin. N. Amer., 1995, 24, 395-404.